1) peripheral venous catheterization
外周静脉插管
2) peripherally inserted central catheters
经外周至中心静脉插管
1.
Objective To determine the advantages and disadvantages of peripherally inserted central catheters (PICC) and femoral venous catheters (FVC) in the treatment of respiratory diseases.
目的比较经外周至中心静脉插管(PICC)与股静脉穿刺插管(简称股穿)的优缺点。
3) PICC
经外周插管的中心静脉导管
1.
Influence of PICC catheter pretreatment on the mechanical phlebitis in breast cancer patients receiving chemotherapy;
经外周插管的中心静脉导管的预处理对乳腺癌化疗患者机械性静脉炎发生率的影响
4) Peripheral Vein
外周静脉
1.
A Comparison of Chemotherapeutic Effect by Indwelling Transfusion Via External Jugular Vein and Peripheral Vein;
颈外静脉与外周静脉留置化疗输液的效果比较
2.
Methods In according to the pathologic types of the primary tumors,the distinction of action and metabolism of chemicals,the cell cycle nonspecific agents(CCNSA) to be infused or add to embolism by the liver artery (except CTX and IFO),the cell cycle specific agents (CCSA) to be injected by peripheral vein,from each chemotherapy scheme.
方法 根据原发肿瘤病理类型、化疗药物作用特点及代谢特征 ,将每一化疗方案中细胞周期非特异性药物 (环磷酰胺、异环磷酰胺除外 )经肝动脉灌注或栓塞 ,细胞周期特异性药物经外周静脉给药。
3.
Methods The modified PICC through the femoral vein to the inferior vena cava was performed in 1 patient with cardiac pacemaker,1 patient with burnt arms,3 patients with neoplasm and 16 patients who had undergone unsuccessful PICC through the peripheral vein.
方法对21例患者实施经股静脉穿刺PICC导管置入下腔静脉,患者分别为装有心脏起搏器和双上肢烧伤各1例、肿瘤患者静脉条件差3例、PICC导管经外周静脉穿刺失败16例。
5) peripherally inserted central catheter
外周置入中心静脉导管
1.
Objective To analyze the causes of complication of peripherally inserted central catheter(PICC) to senile stroke patients and propose prevention strategies.
目的分析外周置入中心静脉导管(PICC)在老年脑卒中患者应用发生并发症的原因,并提出预防对策。
补充资料：门静脉插管化疗栓塞术
门静脉插管化疗栓塞术
the chemo?embolization of portal vein
由门静脉属支插管至或近门静脉的肿瘤分支，经该导管进行化学栓塞治疗的方法。门静脉参与肝癌血供及门静脉癌栓是肝癌肝内转移、复发及影响其预后的重要因素。故通过脐静脉、胃网膜静脉、回结肠静脉或经皮肝门静脉穿刺插管等方式，将导管送至或近其肿瘤分支处，如用带球囊导管则先膨胀球囊以防止栓塞剂反流，经导管注入抗癌药及栓塞剂；常用抗癌药有阿霉素、丝裂霉素、氟尿嘧啶、顺铂等；栓塞剂如碘油、明胶海绵粒、自凝血块、纤维蛋白等。该法常与肝动脉栓塞术合并使用，疗效较单一栓塞术好。肿瘤及门静脉癌栓的坏死率更高，但相应的肝组织损伤较大，须掌握好其适应证。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条